NHS

Showing 15 posts of 1107 posts found.

beam

Proton beam therapy finally arrives in UK

April 4, 2018
Medical Communications, Research and Development NHS, Proton beam therapy, biotech, drugs, pharma, pharmaceutical

28 years after the US first pioneered proton beam therapy at Loma Linda University Medical Center, the UK now has …

One centre for cancer diagnoses trialled

April 3, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer …

theresa_may_-_credit_arno_mikkor

May hints at providing long-term funding plan for NHS

March 28, 2018
Medical Communications, Research and Development Conservatives, NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

After the news broke earlier in the week of a group of nearly 100 MPs calling for a parliamentary commission …

May faces pressure for cross-party talks over NHS future

March 26, 2018
Medical Communications, Sales and Marketing NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

A group of close to 100 MPs have demanded that Theresa May set up a parliamentary commission to plot the …

Rising levels of opioid prescriptions puts NHS under pressure

March 16, 2018
Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical

It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …

philip_hammond

Hammond suggests NHS may receive cash boost

March 14, 2018
Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …

mri_credit_-_ptrump16

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018
Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …

nhs_sign

UK Government announces prescription price hike to record level

February 27, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …

nhs_trees

UK to crack down on 237m annual medication errors

February 23, 2018
Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical

A new study commissioned by the Department of Health and Social Care has revealed that 237 million medication errors are …

kardia_mobile_give_credit_to_alivecor

Smartphone ECG device KardiaMobile rolled out to NHS to combat atrial fibrillation

February 14, 2018
Research and Development KardiaMobile, NHS, atrial fibrillation, pharma

AliveCor has announced that it has begun the rollout of its KardiaMobile technology to the NHS via the UK’s Academic …

NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma

February 12, 2018
Sales and Marketing Gazyvaro, NHS, NICE, Roche, follicular lymphoma

Roche has announced that NICE has issued its final decision to recommend the use of its Gazyvaro (obinutuzumab). The glyco-engineered …

flu

NHS tells doctors to order stronger vaccine for next winter

February 7, 2018
Medical Communications, Research and Development NHS, biotech, drugs, flu season, pharma, pharmaceutical

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …

shutterstock_158366573

UK GPs are “undervalued” with 40% looking to quit profession, study finds

February 5, 2018
Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma

Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …

Faslodex rejected by NICE for NHS breast cancer use

February 2, 2018
Research and Development, Sales and Marketing AstraZeneca, Faslodex, NHS, NICE, UK, pharma

Bad news for breast cancer patients in the UK as the National Institute for Health and Care Excellence announces it …

The Gateway to Local Adoption Series

Latest content